Drug makers may profit from disease in global warming scourge

authordefault
on

A report by PricewaterhouseCoopers LLP forecast that higher temperatures could lead to a doubling of the world pharmaceutical market in 13 years , with sales of medicines increasing to $1.3 trillion US from about $600 billion last year โ€“ provided drug makers find innovativeย treatments.

The New York-based accounting and consulting company, citing the Intergovernmental Panel on Climate Change, said the average temperature is projected to increase by 0.4 degrees Celsius during the next two decades and the increase could be greater if greenhouse-gas emissionsย increase.

Climate change may already be playing a role in reports of malaria in countries such as Turkey and Georgia where it was eradicated, the reportย said.

Related Posts

on

The think tank has received extensive funding from U.S. tech interests.

The think tank has received extensive funding from U.S. tech interests.
on

Celebrity chefsโ€™ platform teams up with controversial seafood label, which certifies seafood linked to food insecurity and overfishing in West Africa.

Celebrity chefsโ€™ platform teams up with controversial seafood label, which certifies seafood linked to food insecurity and overfishing in West Africa.
on

From the One Big Beautiful Bill to a pipeline โ€œloophole,โ€ a new report highlights industry influence on EPA and Congress to reverse climate rules.

From the One Big Beautiful Bill to a pipeline โ€œloophole,โ€ a new report highlights industry influence on EPA and Congress to reverse climate rules.
Series: MAGA
Analysis
on

Black & Veatch, the company behind Goldfinch Technology Park, donates to Republican politicians through its political action committee.

Black & Veatch, the company behind Goldfinch Technology Park, donates to Republican politicians through its political action committee.